IndraLab

Statements

6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one inhibits CASP1. 3 / 3
| 3
reach
"Furthermore, R406 inhibited caspase-1 activity after CaP particle exposure, as assessed by quantitative live cell imaging (XREF_FIG D), with no effect on VSMC death (Supplement Fig."
29274344
reach
"On the other hand, LFM-A13 and R406 suppressed IL-1beta secretion and caspase-1 activation without affecting pro-IL-1beta accumulation in THP-1-Mphi (XREF_FIG)."
26059659
reach
"The SYK inhibitor R406 reduced IL-1beta release and caspase-1 activation in CaP particle treated VSMCs, indicating that SYK activation occurs upstream of and is required for caspase-1 activation."
29274344